IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RONCA, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.500
EU - Europa 4.711
AS - Asia 1.333
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 9
AF - Africa 7
Totale 12.581
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.478
PL - Polonia 2.510
CN - Cina 738
UA - Ucraina 637
IT - Italia 459
DE - Germania 443
HK - Hong Kong 240
FI - Finlandia 172
GB - Regno Unito 151
SG - Singapore 137
IE - Irlanda 130
VN - Vietnam 93
IN - India 56
FR - Francia 47
RU - Federazione Russa 42
CZ - Repubblica Ceca 30
BE - Belgio 29
SE - Svezia 20
CA - Canada 19
TR - Turchia 13
AU - Australia 11
ES - Italia 10
EU - Europa 9
IR - Iran 9
JP - Giappone 7
NL - Olanda 7
CH - Svizzera 6
KR - Corea 6
PH - Filippine 6
TW - Taiwan 5
LK - Sri Lanka 4
AR - Argentina 3
BD - Bangladesh 3
MA - Marocco 3
MU - Mauritius 3
PE - Perù 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
GR - Grecia 2
KG - Kirghizistan 2
LT - Lituania 2
NO - Norvegia 2
PA - Panama 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
ID - Indonesia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 12.581
Salva come PNG Salva come JPEG
Città #
Warsaw 2.508
Fairfield 1.066
Woodbridge 670
Ashburn 601
Jacksonville 495
Houston 476
Cambridge 412
Seattle 396
Ann Arbor 348
Chandler 347
Wilmington 333
Brescia 262
Princeton 237
Hong Kong 236
Nanjing 152
Beijing 142
New York 127
Dublin 124
Dearborn 123
Helsinki 103
Dong Ket 90
Singapore 86
Des Moines 59
Shanghai 58
Nanchang 48
Shenyang 46
Hebei 40
San Diego 39
Jinan 36
Los Angeles 36
Changsha 35
Milan 32
Lancaster 28
Brno 27
Brussels 27
Tianjin 27
San Francisco 22
Boardman 20
Phoenix 20
Kunming 18
London 18
Munich 16
Hangzhou 15
Taizhou 15
San Mateo 14
Washington 14
Jiaxing 13
Ningbo 13
Haikou 12
Hefei 10
Nürnberg 10
Kocaeli 9
Rome 9
Zhengzhou 9
Lanzhou 8
Ottawa 8
Toronto 8
Verona 8
Ardabil 7
Kilburn 7
Lappeenranta 7
Norwalk 7
Redwood City 7
Augusta 6
Boston 6
Chicago 6
Guangzhou 6
Orange 6
Turin 6
Acton 5
Florence 5
Fuzhou 5
Gunzenhausen 5
Salerno 5
Taipei 5
Taiyuan 5
Zurich 5
Calvisano 4
Colombo 4
Leawood 4
Lonate Ceppino 4
Palermo 4
Pavia 4
Pune 4
Tokyo 4
Urbino 4
Wuhan 4
Angeles City 3
Baliuag 3
Barcelona 3
Canberra 3
Changchun 3
Chiswick 3
Dresden 3
Falkenstein 3
Lima 3
Lumezzane 3
New Delhi 3
Padova 3
Rabat 3
Totale 10.351
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 277
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 245
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 237
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 228
Tumor angiogenesis revisited: Regulators and clinical implications 228
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 223
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 222
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 219
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 216
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 214
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 213
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 208
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 207
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 201
Caveolin-1 overexpression accelerates tumor growth and metastasis of embryonal rhabdomyosarcoma 199
Caveolin-1 overexpression in the human embryonal rhabdomyosarcoma RD cells increases tumor growth and metastasis in vivo through a phospho-ERK-dependent signaling pathway 198
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 197
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 196
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 189
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 185
Stromal delivery of long Pentraxin-3 impairsFGF7FGFR-dependent tumor growth and metastasis 185
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 160
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 154
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 153
Long pentraxin-3 follows and modulates bladder cancer progression 152
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 151
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 146
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 138
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 137
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 133
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 132
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 131
Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors 130
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 129
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 126
Synthesis, in vitro and in vivo biological evaluation of substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones as new potent anticancer agents 124
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 122
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 121
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 119
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 117
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 117
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 116
Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors 116
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 115
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 114
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 110
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 109
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 109
Beta-Galactosylceramidase deficiency: neurovascular implications 108
Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis 108
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 108
Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2 107
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation 106
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 103
Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor β signalling pathway 103
Heparin derivatives as angiogenesis inhibitors 102
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 102
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome 102
Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones 101
Long pentraxin 3: A novel multifaceted player in cancer 101
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 98
Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-Assemblies 96
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 93
The autocrine fgf/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach 92
Future applications of FGF/FGFR inhibitors in cancer 92
Vascular disrupting activity of combretastatin analogues 91
FGF Ligand Traps for the Therapy of FGF-Dependent Tumors 90
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 86
Circulating microRNAs and Their Role in Multiple Myeloma 85
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 83
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 83
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 82
HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies 80
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 80
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 78
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 77
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 76
The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease 74
Krabbe Disease and zebrafish: key-role of galactocerebrosidase in CNS development 73
PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma 70
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 69
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 66
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 62
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells 62
TR-764 is a novel tubulin binding agent with strong antiangiogenic activity. 62
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 61
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 57
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 57
Fibroblast growth factor receptor-1 and cardiomyocyte development in murine embryonic stem cells 53
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 53
LONG PENTRAXIN-3 INHIBITS FGF-DEPENDENT ANGIOGENESIS AND GROWTH OF STEROID HORMONE-REGULATED TUMORS 52
Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes 52
Role of FGFR1 in cardiovascular development:new insight from embryonic stem cells 51
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 51
Suppressive and activating antigen presenting cells originate from a common myeloid precursor 50
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 50
The FGF/FGFR System in the Physiopathology of the Prostate Gland 50
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 49
Computer-assisted analysis of endothelial cell sprouting: an in vitro assay for the screening of anti-angiogenic compounds 46
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 46
Totale 11.997
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.361 0 0 193 375 289 475 421 428 334 435 201 210
2020/20212.366 94 235 95 274 143 227 151 253 255 247 238 154
2021/20221.124 88 199 47 27 19 53 73 74 45 116 100 283
2022/20231.027 175 32 57 56 99 241 6 90 145 4 64 58
2023/20241.263 76 30 136 54 48 207 52 73 260 63 56 208
2024/202574 34 40 0 0 0 0 0 0 0 0 0 0
Totale 12.918